FindTrial
Sign In

Prediction of molecular typing of glioma by quantitative detection of 2HG, Gly and Gln based on 7T-MRS technology

Prediction of molecular typing of glioma by quantitative detection of 2HG, Gly and Gln based on 7T-MRS technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092673
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-11-26
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult diffuse gliomas

Interventions

IDH wild-type group:None
IDH mutant group:None

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Suspected brain glioma patients before surgery; 2.Age greater than 18 years; 3.Karnofsky Performance Status (KPS) score greater than 60; 4.No history of other neurological diseases.

Exclusion criteria

Exclusion criteria: 1.Presence of contraindications for magnetic resonance imaging (MRI); 2.Patients unable to complete the MRI examination.

Design outcomes

Primary

MeasureTime frame
2HG;Gly;Gln;—

Countries

China

Contacts

Public ContactXiaofei Hu

The First Affiliated Hospital of Army Medical University, PLA

harryzonetmmu@163.com+86 23 68766578

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026